1st Quarter - Report
TIBER CREEK GROUP for AMGEN INC
Firm
Client
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues relating to Part D pricing reform; Issues relating to Part B pricing reform; Issues relating to Part B home infusion; Issues related to Part B refunds for discarded amounts of certain single-dose container or single-use package drugs; H.R. 1319 - American Rescue Plan Act of 2021, SEC. 9816, SUNSET OF LIMIT ON MAXIMUM REBATE AMOUNT FOR SINGLE SOURCE DRUGS AND INNOVATOR MULTIPLE SOURCE DRUGS.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| JAMES HEIMBACH | — |
| JONATHON JONES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.